• Alaska Air Group: Morgan Stanley maintains its Overweight rating and lowers the price target from $85 to $83.
  • Alexandria Real Estate Equities: BNP Paribas Exane maintains its Neutral rating and lowers the price target from $111 to $85.
  • Bristol-Myers Squibb: DZ Bank AG Research maintains its Buy rating and lowers the price target from $61 to $56.
  • Cadence Design Systems: JP Morgan maintains its Overweight rating and raises the price target from $325 to $330.
  • Campbell Soup: Bernstein maintains its Outperform rating and lowers the price target from $48 to $47.
  • Colgate-Palmolive: DZ Bank AG Research maintains its Sell rating and raises the price target from $79 to $80.
  • Dayforce: Citigroup maintains its Buy rating and lowers the price target from $78 to $68.
  • Equifax: Redburn Atlantic maintains a Neutral rating and raises the price target from $245 to $275.
  • Gilead Sciences: DZ Bank AG Research maintains its Buy rating and raises the price target from $108 to $116.
  • Hamilton Lane: JP Morgan maintains its Neutral rating and lowers the price target from $176 to $167.
  • Icon: JP Morgan downgrades from Overweight to Neutral and lowers the price target from $265 to $150.
  • Intel: DZ Bank AG Research maintains its Sell rating and lowers the price target from $18 to $17.
  • Meta Platforms: Bernstein maintains its Outperform rating and lowers the price target from $800 to $700.
  • NRG Energy: Morgan Stanley maintains its Equal-weight rating and raises the price target from $99 to $104.
  • Paylocity Holding: Citigroup maintains its Buy rating and lowers the price target from $246 to $225.
  • Pinterest: Bernstein maintains its Outperform rating and lowers the price target from $47 to $35.
  • Progressive: Morgan Stanley maintains its Overweight rating and raises the price target from $310 to $320.
  • SBA Communications: Citigroup maintains its Buy rating and raises the price target from $250 to $265.
  • Snap: Bernstein maintains its Market Perform rating and lowers the price target from $12 to $10.
  • Welltower: BNP Paribas Exane maintains its Outperform rating and raises the price target from $163 to $164.